ONCORUS INC (ONCR) Fundamental Analysis & Valuation

NASDAQ:ONCR • US68236R1032

Current stock price

0.1206 USD
-0.01 (-8.5%)
Last:

This ONCR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ONCR Profitability Analysis

1.1 Basic Checks

  • In the past year ONCR has reported negative net income.
  • ONCR had a negative operating cash flow in the past year.
ONCR Yearly Net Income VS EBIT VS OCF VS FCFONCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

  • The profitability ratios for ONCR are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONCR Yearly ROA, ROE, ROICONCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

  • ONCR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONCR Yearly Profit, Operating, Gross MarginsONCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ONCR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ONCR has been increased compared to 1 year ago.
  • Compared to 1 year ago, ONCR has a worse debt to assets ratio.
ONCR Yearly Shares OutstandingONCR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
ONCR Yearly Total Debt VS Total AssetsONCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -5.89, we must say that ONCR is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -5.89, ONCR is not doing good in the industry: 68.01% of the companies in the same industry are doing better.
  • ONCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.89
ROIC/WACCN/A
WACCN/A
ONCR Yearly LT Debt VS Equity VS FCFONCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

2.3 Liquidity

  • ONCR has a Current Ratio of 1.50. This is a normal value and indicates that ONCR is financially healthy and should not expect problems in meeting its short term obligations.
  • ONCR's Current ratio of 1.50 is on the low side compared to the rest of the industry. ONCR is outperformed by 81.67% of its industry peers.
  • ONCR has a Quick Ratio of 1.50. This is a normal value and indicates that ONCR is financially healthy and should not expect problems in meeting its short term obligations.
  • ONCR has a Quick ratio of 1.50. This is amonst the worse of the industry: ONCR underperforms 80.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
ONCR Yearly Current Assets VS Current LiabilitesONCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ONCR Growth Analysis

3.1 Past

  • ONCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.78%.
EPS 1Y (TTM)-28.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ONCR will show a very strong growth in Earnings Per Share. The EPS will grow by 21.17% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y34.04%
EPS Next 2Y30.28%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ONCR Yearly Revenue VS EstimatesONCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 10K 20K 30K 40K
ONCR Yearly EPS VS EstimatesONCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

1

4. ONCR Valuation Analysis

4.1 Price/Earnings Ratio

  • ONCR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ONCR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONCR Price Earnings VS Forward Price EarningsONCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONCR Per share dataONCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ONCR's earnings are expected to grow with 21.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.28%
EPS Next 3Y21.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ONCR Dividend Analysis

5.1 Amount

  • ONCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ONCR Fundamentals: All Metrics, Ratios and Statistics

ONCORUS INC

NASDAQ:ONCR (6/20/2023, 8:14:14 PM)

0.1206

-0.01 (-8.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-22
Earnings (Next)08-02
Inst Owners9.11%
Inst Owner Change0%
Ins Owners11.14%
Ins Owner Change0%
Market Cap3.15M
Revenue(TTM)N/A
Net Income(TTM)-90.54M
Analysts45.71
Price Target5.1 (4128.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.88%
Min EPS beat(2)-65.27%
Max EPS beat(2)-4.49%
EPS beat(4)1
Avg EPS beat(4)-17.24%
Min EPS beat(4)-65.27%
Max EPS beat(4)1.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)53.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.1
EV/EBITDA N/A
EPS(TTM)-3.49
EYN/A
EPS(NY)-0.91
Fwd EYN/A
FCF(TTM)-2.83
FCFYN/A
OCF(TTM)-2.13
OCFYN/A
SpS0
BVpS1.19
TBVpS1.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 437.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -5.89
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)372.13%
Cap/Depr(5y)247.64%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.01%
EPS Next Y34.04%
EPS Next 2Y30.28%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.81%
OCF growth 3YN/A
OCF growth 5YN/A

ONCORUS INC / ONCR Fundamental Analysis FAQ

What is the fundamental rating for ONCR stock?

ChartMill assigns a fundamental rating of 2 / 10 to ONCR.


What is the valuation status of ONCORUS INC (ONCR) stock?

ChartMill assigns a valuation rating of 3 / 10 to ONCORUS INC (ONCR). This can be considered as Overvalued.


Can you provide the profitability details for ONCORUS INC?

ONCORUS INC (ONCR) has a profitability rating of 1 / 10.


Can you provide the financial health for ONCR stock?

The financial health rating of ONCORUS INC (ONCR) is 2 / 10.